全文获取类型
收费全文 | 2203篇 |
免费 | 126篇 |
国内免费 | 7篇 |
专业分类
耳鼻咽喉 | 13篇 |
儿科学 | 81篇 |
妇产科学 | 73篇 |
基础医学 | 278篇 |
口腔科学 | 76篇 |
临床医学 | 186篇 |
内科学 | 404篇 |
皮肤病学 | 27篇 |
神经病学 | 128篇 |
特种医学 | 268篇 |
外科学 | 275篇 |
综合类 | 26篇 |
预防医学 | 158篇 |
眼科学 | 62篇 |
药学 | 166篇 |
中国医学 | 1篇 |
肿瘤学 | 114篇 |
出版年
2021年 | 20篇 |
2020年 | 23篇 |
2019年 | 22篇 |
2018年 | 25篇 |
2017年 | 24篇 |
2016年 | 28篇 |
2015年 | 25篇 |
2014年 | 46篇 |
2013年 | 57篇 |
2012年 | 81篇 |
2011年 | 99篇 |
2010年 | 67篇 |
2009年 | 63篇 |
2008年 | 75篇 |
2007年 | 96篇 |
2006年 | 68篇 |
2005年 | 69篇 |
2004年 | 72篇 |
2003年 | 90篇 |
2002年 | 70篇 |
2001年 | 45篇 |
2000年 | 63篇 |
1999年 | 45篇 |
1998年 | 59篇 |
1997年 | 70篇 |
1996年 | 65篇 |
1995年 | 61篇 |
1994年 | 59篇 |
1993年 | 42篇 |
1992年 | 46篇 |
1991年 | 41篇 |
1990年 | 56篇 |
1989年 | 47篇 |
1988年 | 53篇 |
1987年 | 44篇 |
1986年 | 57篇 |
1985年 | 51篇 |
1984年 | 26篇 |
1983年 | 29篇 |
1982年 | 28篇 |
1981年 | 16篇 |
1980年 | 19篇 |
1979年 | 27篇 |
1978年 | 20篇 |
1977年 | 23篇 |
1976年 | 29篇 |
1975年 | 10篇 |
1974年 | 17篇 |
1973年 | 12篇 |
1970年 | 12篇 |
排序方式: 共有2336条查询结果,搜索用时 459 毫秒
91.
The effects of recombinant-DNA-derived interferons on the growth of myeloid progenitor cells 总被引:5,自引:0,他引:5
Interferons (IFNs) have been shown to have significant effects on hematopoietic cell growth. Previous studies defining these effects have utilized mouse and human alpha-, beta-, and gamma-IFN isolated from supernatants of stimulated cells. Despite purification, the possible presence of other lymphokines and soluble factors remains a concern. In this study, the effects of gene-cloned alpha- and gamma-IFN on colony- forming units of granulocyte/macrophage (CFU-GM) progenitors cultured from the peripheral blood of normal volunteers were examined. In addition, blast cell colonies from one patient with acute myelogenous leukemia (AML) were studied. The growth of normal CFU-GM and AML blast cell colonies was inhibited in a dose-dependent manner by gamma- and alpha-IFN. gamma-IFN was ten to 100 times more potent than alpha-IFN in that this species of IFN reduced colony formation by greater than 50% at concentrations of less than 15 antiviral U/mL. The effects of gamma- IFN were neutralized by a monoclonal antibody specific for gamma-IFN. These in vitro studies indicate that human gamma-IFN may be an important modulator of myelopoiesis. Although these data indicate a possible efficacy of gamma-IFN in the treatment of AML, the in vitro results should be considered for their in vivo significance. 相似文献
92.
93.
R. W. Kaminski M. Wu K. R. Turbyfill K. Clarkson B. Tai A. L. Bourgeois L. L. Van De Verg R. I. Walker E. V. Oaks 《Clinical and Vaccine Immunology : CVI》2014,21(3):366-382
Studies were undertaken to manufacture a multivalent Shigella inactivated whole-cell vaccine that is safe, effective, and inexpensive. By using several formalin concentrations, temperatures, and incubation periods, an optimized set of inactivation conditions was established for Shigella flexneri 2a, S. sonnei, and S. flexneri 3a to produce inactivated whole cells expressing a full repertoire of Ipa proteins and lipopolysaccharide (LPS). The inactivation conditions selected were treatment with 0.2% formalin (S. flexneri 2a and 3a) or 0.6% formalin (S. sonnei) for 48 h at 25°C. Vaccine formulations prepared under different inactivation conditions, in different doses (10E5, 10E7, and 10E9 cells), and with or without the inclusion of double-mutant heat-labile toxin (dmLT) were evaluated in mice. Two intranasal immunizations with ≥10E7 inactivated whole cells resulted in high levels of anti-Invaplex and moderate levels of LPS-specific IgG and IgA in serum and in lung and intestinal wash samples. Addition of dmLT to the vaccine formulations did not significantly enhance humoral immunogenicity. Minimal humoral responses for IpaB, IpaC, or IpaD were detected after immunization with inactivated whole Shigella cells regardless of the vaccine inactivation conditions. In guinea pigs, monovalent formulations of S. flexneri 2a of 3a or S. sonnei consisting of 10E8, 10E9, or 10E10 cells were protective in a keratoconjunctivitis assay. A trivalent formulation provided protection against all three serotypes (S. flexneri 2a, P = 0.018; S. flexneri 3a, P = 0.04; S. sonnei, P < 0.0001). The inactivated Shigella whole-cell vaccine approach incorporates an uncomplicated manufacturing process that is compatible with multivalency and the future development of a broadly protective Shigella vaccine. 相似文献
94.
95.
96.
Marret S Ancel PY Marpeau L Marchand L Pierrat V Larroque B Foix-L'Hélias L Thiriez G Fresson J Alberge C Rozé JC Matis J Bréart G Kaminski M;Epipage Study Group 《Obstetrics and gynecology》2007,110(1):72-80
OBJECTIVE: To evaluate the rates of in-hospital death, neonatal complications, and 5-year outcomes of infants born at 30-34 weeks of gestation. METHODS: In nine regions of France, all 2,020 stillbirths and live births at 30, 31, and 32 weeks in 1997 and all 457 births at 33 and 34 weeks in April and October 1997 were recorded. Survivors were evaluated at 5 years of age. RESULTS: Increasing gestational age from 30 to 34 weeks was associated with progressive decreases in in-hospital mortality (from 8.1% to 0.4%) and neonatal complications (respiratory distress syndrome, 43.8% to 2.6%; maternofetal infections, 7.2% to 2.6%; and severe white matter injury, 5.5% to 1.3%). Although infants at 33 and 34 weeks of gestation rarely experienced necrotizing enterocolitis, bronchopulmonary dysplasia, or nosocomial infections, they still required endotracheal ventilation, antibiotics, or parenteral nutrition. At 5 years of age, older gestational age was associated with significant decreases in rates of cerebral palsy (6.3% at 30 weeks and 0.7% at 34 weeks) and mild to severe cognitive impairments (35.3% at 30 weeks and 23.9% at 34 weeks). In singletons, preterm rupture of membranes or preterm labor carried an increased risk of cerebral palsy but not of cognitive impairment. CONCLUSION: Neonates born at 30-34 weeks experienced substantial morbidity and often required admission to neonatal intensive care units. These outcomes suggest that prolonging pregnancies beyond 34 weeks may be desirable whenever possible. Infants born at 30-34 weeks should be carefully monitored to ensure prompt detection and management of neurodevelopmental impairment. 相似文献
97.
Arianne C Lim Kitty WM Bloemenkamp Kees Boer Johannes J Duvekot Jan Jaap HM Erwich Tom HM Hasaart Pieter Hummel Ben WJ Mol Jos PM Offermans Charlotte M van Oirschot Job G Santema Hubertina CJ Scheepers Willem A Schöls Frank PHA Vandenbussche Maurice GAJ Wouters Hein W Bruinse 《BMC pregnancy and childbirth》2007,7(1):1-6
Background
Adequate vitamin D concentrations during pregnancy are necessary to neonatal calcium homeostasis, bone maturation and mineralization. The aim of study is to evaluate serum vitamin D concentrations in mothers and their newborns and effect of vitamin D deficiency on pregnancy outcomes.Methods
552 pregnant women were recruited from Tehran University educating hospitals in the winter of 2002. Maternal and cord blood samples were taken at delivery. The serum was assayed for 25-hydroxyvitamin D3, calcium, phosphorus and parathyroid hormone.Results
The prevalence of vitamin D deficiency in maternal and cord blood samples were 66.8% and 93.3%, respectively (<35 nmol/l). There was significant correlation between maternal and cord blood serum concentrations of vitamin D. In mothers with vitamin D deficiency, cord blood vitamin D concentrations was lower than those from normal mothers (P = .001). Also, a significant direct correlation was seen between maternal vitamin D intake and weight gain during pregnancy.Conclusion
Consideration to adequate calcium and vitamin D intake during pregnancy is essential. Furthermore, we think it is necessary to reconsider the recommendation for vitamin D supplementation for women during pregnancy. 相似文献98.
99.
Ruth Chia Sara Saez-Atienzar Natalie Murphy Adriano Chi Cornelis Blauwendraat International Myasthenia Gravis Genomics Consortium Ricardo H. Roda Pentti J. Tienari Henry J. Kaminski Roberta Ricciardi Melania Guida Anna De Rosa Loredana Petrucci Amelia Evoli Carlo Provenzano Daniel B. Drachman Bryan J. Traynor 《Proceedings of the National Academy of Sciences of the United States of America》2022,119(5)
100.
目的 克隆人2型大麻受体(hCB2)基因,并构建相应的稳定表达细胞株.方法 利用人T淋巴细胞株HPB-ALL的总RNA,以RT-PCR及酶切、连接等分子生物学方法克隆hCB2基因于质粒载体pFlag-CMV-3内,以HEK293细胞构建稳定表达细胞株,以Western blot方法利用蛋白标记Flag的单克隆抗体(Anti-Flag)和CB2多克隆抗体(Anti-CB2)同时检测质粒的表达.结果 酶切及测序结果表明hCB2基因克隆成功,Western blot检测结果表明Anti-Flag和Anti-CB2都能检测Flag-hCB2蛋白.结论 成功克隆hCB2基因,并获得稳定表达细胞株,同时证实Anti-CB2多克隆抗体有效. 相似文献